Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Metabolism: Clinical and Experimental

• Publication date

  1986-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0026-0495(86)90199-XPMID 3083202
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Purification and properties of aldose reductase and aldehyde reductase II from human erythrocyte.

  1985cited by this paper
• Purification and properties of aldehyde reductases from human placenta.

  1985cited by this paper
• Activation of Aldose Reductase from Human Tissues

  1985cited by this paper
• Interrelationships among human aldo-keto reductases: immunochemical, kinetic and structural properties.

  1985cited by this paper
• Activated and unactivated forms of human erythrocyte aldose reductase.

  1985cited by this paper
• Aldose and aldehyde reductases in human tissues.

  1984cited by this paper
• Aldose and aldehyde reductases in human ocular tissues

  1984cited by this paper
• Red Blood Cell Sorbitol as an Indicator of Polyol Pathway Activity: Inhibition by Sorbinil in Insulin-dependent Diabetic Subjects

  1984cited by this paper
• Purification and properties of human liver aldehyde reductases.

  1982cited by this paper
• Desmosines in aneurysms of the ascending aorta (annulo-aortic ectasia).

  1982cited by this paper
• Altering the course of cataracts in diabetic rats.

  1980cited by this paper
• CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.

  1979cited by this paper
• Aldose reductase in retinal mural cells.

  1977cited by this paper
• Mechanisms initiating cataract formation. Proctor Lecture.

  1974cited by this paper
• Purification and Immunologic Identification of Aldose Reductases

  1974cited by this paper
• The sorbitol pathway and the complications of diabetes.

  1973cited by this paper
• Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor

  1973cited by this paper
• Glucose utilization by the polyol pathway in human erythrocytes.

  1970cited by this paper
• Sorbitol Pathway: Presence in Nerve and Cord with Substrate Accumulation in Diabetes

  1966cited by this paper

• Role of RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease

  2021cites this paper
• RALBP1 in Oxidative Stress and Mitochondrial Dysfunction in Alzheimer’s Disease

  2021cites this paper
• Efficacy of aldose reductase inhibitors is affected by oxidative stress induced under X-ray irradiation

  2019cites this paper
• AKR1B1 at 1.65 MGy radiation dose.

  2019cites this paper
• Development of novel oxotriazinoindole inhibitors of aldose reductase: isosteric sulfur/oxygen replacement in the thioxotriazinoindole cemtirestat markedly improved inhibition selectivity.

  2019cites this paper
• Ketone Body Acetoacetate Buffers Methylglyoxal via a Non-enzymatic Conversion during Diabetic and Dietary Ketosis.

  2017cites this paper
• In vitro aldose reductase inhibitory potential of fractions isolated from Potentilla fulgens roots

  2016cites this paper
• Effect of Different Solvent Extracts of Potentilla Fulgens L. on Aldose Reductase and Sorbitol Dehydrogenase in &ormoglycemic and Diabetic Mice

  2011cites this paper
• Substituted derivatives of indole acetic acid as aldose reductase inhibitors with antioxidant activity: structure-activity relationship.

  2011cites this paper
• The Role of Cys-298 in Aldose Reductase Function*

  2010cites this paper
• Anti‐ischaemic activity of an antioxidant aldose reductase inhibitor on diabetic and non‐diabetic rat hearts

  2010cites this paper
• Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts

  2008cites this paper
• In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats.

  2006cites this paper
• Characterization of Binding Pocket Flexibility of Aldose Reductase

  2006cites this paper
• The role of polyols in the pathophysiology of hypergalactosemia

  2005cites this paper
• Aldose Reductase and AGE‐RAGE Pathways: Key Players in Myocardial Ischemic Injury

  2005cites this paper
• Effects of aldose reductase inhibition with tolrestat on diabetic retinopathy in a six months double blind trial

  2005cites this paper
• Central role for aldose reductase pathway in myocardial ischemic injury

  2004cites this paper
• All in the family: aldose reductase and closely related aldo-keto reductases

  2004cites this paper
• Glucose , Glycation , and RAGE : Implications for Amplification of Cellular Dysfunction in Diabetic

  2003cites this paper
• Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy.

  2003cites this paper
• Aldose reductase activation is a key component of myocardial response to ischemia

  2002cites this paper
• Aldose reductase activity and glucose-related opacities in incubated lenses from dogs and cats.

  2002cites this paper
• Nitric oxide prevents aldose reductase activation and sorbitol accumulation during diabetes.

  2002cites this paper
• Determination of D-sorbitol in human erythrocytes by an enzymatic fluorometric method with an improved deproteinization procedure

  2001cites this paper
• In vitro inhibition of glucose phosphorylation by an aldose-reductase inhibitor (Tolrestat) in some non-insulin-sensitive rabbit tissues.

  1999cites this paper
• Improved fluorometric enzymatic sorbitol assay in human blood.

  1998cites this paper
• Oxidative defense enzyme activity and mRNA levels in lenses of diabetic rats.

  1997cites this paper
• Oxidized aldose reductase: in vivo factor not in vitro artifact.

  1996cites this paper
• Increased white cell aldose reductase mRNA levels in diabetic patients.

  1996cites this paper
• The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

  1995cites this paper
• The Efficacy of Aldose Reductase Inhibitors in the Management of Diabetic Complications

  1995cites this paper
• Effect of ageing on erythrocyte aldose reductase and sorbitol dehydrogenase activity.

  1994cites this paper
• Effect of Aldose Reductase Inhibitor (Tolrestat) on Urinary Albumin Excretion Rate and Glomerular Filtration Rate in IDDM Subjects With Nephropathy

  1993cites this paper
• Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells.

  1993cites this paper
• Carboxymethylation-induced activation of bovine lens aldose reductase.

  1992cites this paper
• Effects of glucose, insulin or aldose reductase inhibition on responses to endothelin‐1 of aortic rings from streptozotocin‐induced diabetic rats

  1992cites this paper
• Aldose reductase inhibitors and diabetic complications.

  1992cites this paper
• Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney.

  1992cites this paper
• Aldose reductase: congenial and injurious profiles of an enigmatic enzyme.

  1992cites this paper
• Relationship between erythrocyte sorbitol content and diabetic microangiopathy in patients with non-insulin-dependent diabetes mellitus: the study of a diet loading test.

  1991cites this paper
• Neutrophil Aldose Reductase Activity and its Association with Established Diabetic Microvascular Complications

  1991cites this paper
• Neutrophil Aldose Reductase Activity as a Potential Marker for Neuropathy and Cataract in Diabetes

  1991cites this paper
• Purification and properties of aldose reductase and aldehyde reductase from EHS tumor cells.

  1990cites this paper
• Chromatographic separation of activated and unactivated forms of aldose reductase.

  1990cites this paper
• Effect of Fructose Supplementation on Sorbitol Accumulation and myolnositol Metabolism in Cultured Neuroblastoma Cells Exposed to Increased Glucose Concentrations

  1990cites this paper
• [Erythrocyte sorbitol levels in patients with thyrotoxicosis].

  1990cites this paper
• Change in stereospecificity of bovine lens aldose reductase modified by oxidative stress.

  1989cites this paper
• Polyol pathway activity in streptozotocin-diabetic rat lens.

  1989cites this paper
• Identification of D-sorbitol 3-phosphate in the normal and diabetic mammalian lens.

  1989cites this paper
• Aldose reductase in early streptozotocin-induced diabetic rat lens.

  1989cites this paper
• Pathophysiology of sympathoadrenal system

  1988cites this paper